2012 - How To Establish An Effective Good Clinical Practice in Drugs and Medical Devices
Topics/Call fo Papers
This 90-minute webinar will help you establish an effective Good Clinical Practice (GCP) by providing a current, accurate and complete (CAC) review and understanding of the relevant and applicable regulations for clinical trials or studies, the requirements and compliance in a systematic, integrative (SI) manner.
Why Should You Attend:
To be able to achieve sustainability and to remain sustainable and competitive in global medical product markets, it is necessary to streamline regulatory compliance processes, in particular, the Good Clinical Practice (GCP) for clinical trials and studies and beyond. To establish and maintain GCP, it is critical to accurately define, document and implement “current, accurate, and complete” (CAC) requirements pursuant to the relevant and applicable laws and regulations, GCP requirements, and compliance in a systematic, integrative (SI) manner.
Areas Covered in the Seminar:
- Current, accurate, and complete (CAC) review of FDA regulations including INDs and IDEs.
- Systematic and integrative (SI) analysis of regulations and law governing clinical trials and studies, requirements, and compliance.
- General information for clinical studies.
- Clinical investigators (CI).
- Institutional review boards (IRBs).
- Sponsors.
- Monitors.
- Contract research organizations (CROs).
Why Should You Attend:
To be able to achieve sustainability and to remain sustainable and competitive in global medical product markets, it is necessary to streamline regulatory compliance processes, in particular, the Good Clinical Practice (GCP) for clinical trials and studies and beyond. To establish and maintain GCP, it is critical to accurately define, document and implement “current, accurate, and complete” (CAC) requirements pursuant to the relevant and applicable laws and regulations, GCP requirements, and compliance in a systematic, integrative (SI) manner.
Areas Covered in the Seminar:
- Current, accurate, and complete (CAC) review of FDA regulations including INDs and IDEs.
- Systematic and integrative (SI) analysis of regulations and law governing clinical trials and studies, requirements, and compliance.
- General information for clinical studies.
- Clinical investigators (CI).
- Institutional review boards (IRBs).
- Sponsors.
- Monitors.
- Contract research organizations (CROs).
Other CFPs
- Making All Data Count: FDA Acceptance of non-US Clinical Trials
- Strategic Selection and Development of Immunogenicity Binding Methods
- Recommendations for Cell Banks used in GXP testing
- Eliminate the Confusion ? Analytical Method Qualification and Validation
- Designing Effective and Efficient Extractables/Leachables Studies for Biologics
Last modified: 2012-05-30 19:12:36